Jonathan Jian Wang

Jonathan Jian Wang discloses dealings in 2 companies, chiefly Response Biomedical Corp and ImageneBio, Inc. Between 24 March 2016 and 25 July 2025, the trades on record add up to 10 filings.

Every open-market trade on record is a purchase: 3 purchases worth €444k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants.

A typical purchase (the median) is worth €165k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 15 August 2025: a share grant, in ImageneBio, Inc. The clock since the last published purchase (20 June 2016) now reads 3,777 days. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.